These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 35050985)
1. Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence. Chen JH; Chiang CK Toxins (Basel); 2021 Dec; 14(1):. PubMed ID: 35050985 [TBL] [Abstract][Full Text] [Related]
2. The Role of Gut-Derived, Protein-Bound Uremic Toxins in the Cardiovascular Complications of Acute Kidney Injury. Caillard P; Bennis Y; Six I; Bodeau S; Kamel S; Choukroun G; Maizel J; Titeca-Beauport D Toxins (Basel); 2022 May; 14(5):. PubMed ID: 35622583 [TBL] [Abstract][Full Text] [Related]
3. Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance. Daneshamouz S; Eduok U; Abdelrasoul A; Shoker A NanoImpact; 2021 Jan; 21():100299. PubMed ID: 35559786 [TBL] [Abstract][Full Text] [Related]
4. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis. Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425 [TBL] [Abstract][Full Text] [Related]
5. The AKI-to-CKD Transition: The Role of Uremic Toxins. André C; Bodeau S; Kamel S; Bennis Y; Caillard P Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003343 [TBL] [Abstract][Full Text] [Related]
6. Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure. Di Paola R; De A; Izhar R; Abate M; Zappavigna S; Capasso A; Perna AF; La Russa A; Capasso G; Caraglia M; Simeoni M Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372437 [TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease. Steenbeke M; Valkenburg S; Gryp T; Van Biesen W; Delanghe JR; Speeckaert MM; Glorieux G Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822593 [TBL] [Abstract][Full Text] [Related]
8. AST-120 to Target Protein-Bound Uremic Toxins Improves Cardiac Output and Kidney Oxygenation in Experimental Chronic Kidney Disease. Sivertsson E; Ceder S; Nangaku M; Hansell P; Nordquist L; Palm F Kidney Blood Press Res; 2023; 48(1):114-123. PubMed ID: 36791683 [TBL] [Abstract][Full Text] [Related]
9. Does the Composition of Gut Microbiota Affect Chronic Kidney Disease? Molecular Mechanisms Contributed to Decreasing Glomerular Filtration Rate. Młynarska E; Budny E; Saar M; Wojtanowska E; Jankowska J; Marciszuk S; Mazur M; Rysz J; Franczyk B Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408756 [TBL] [Abstract][Full Text] [Related]
10. Assessment of uremic toxins in advanced chronic kidney disease patients on maintenance hemodialysis by LC-ESI-MS/MS. Ragi N; Pallerla P; Babi Reddy Gari AR; Lingampelly SS; Ketavarapu V; Addipilli R; Chirra N; Kantevari S; Yadla M; Sripadi P Metabolomics; 2023 Feb; 19(3):14. PubMed ID: 36826619 [TBL] [Abstract][Full Text] [Related]
11. The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial. Ebrahim Z; Proost S; Tito RY; Raes J; Glorieux G; Moosa MR; Blaauw R Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215453 [TBL] [Abstract][Full Text] [Related]
12. Acute kidney disease in mice is associated with early cardiovascular dysfunction. Caillard P; Bennis Y; Boudot C; Chatelain D; Rybarczyk P; Boullier A; Poirot S; Titeca-Beauport D; Bodeau S; Choukroun G; Kamel S; Six I; Maizel J Ren Fail; 2024 Dec; 46(2):2415510. PubMed ID: 39422224 [TBL] [Abstract][Full Text] [Related]
13. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease. Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach. Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122 [TBL] [Abstract][Full Text] [Related]
15. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease. Wu CL; Tarng DC Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312 [TBL] [Abstract][Full Text] [Related]
16. Early elimination of uremic toxin ameliorates AKI-to-CKD transition. Chen JH; Chao CT; Huang JW; Hung KY; Liu SH; Tarng DC; Chiang CK Clin Sci (Lond); 2021 Dec; 135(23):2643-2658. PubMed ID: 34796904 [TBL] [Abstract][Full Text] [Related]
17. The Impact of CKD on Uremic Toxins and Gut Microbiota. Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343 [TBL] [Abstract][Full Text] [Related]
18. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets. Lim YJ; Sidor NA; Tonial NC; Che A; Urquhart BL Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33668632 [TBL] [Abstract][Full Text] [Related]